Share
Export Citation
APA
MLA
Chicago
Harvard
Vancouver
BIBTEX
RIS
Universitas Hasanuddin
Research output:Contribution to journal›Article›peer-review
Safety of DW-MSC infusion in patients with low clinical risk COVID-19 infection: a randomized, double-blind, placebo-controlled trial
Karyana M.
Stem Cell Research and Therapy
Q1Published: 2022Citations: 30
Abstract
ClinicalTrials.gov, NCT04535856. Registered 2 September 2020, https://clinicaltrials.gov/ct2/show/NCT04535856.
Access to Document
10.1186/s13287-022-02812-4Other files and links
- Link to publication in Scopus
- Open Access Version Available
Fingerprint
MedicineSciences
TolerabilitySciences
PlaceboSciences
Adverse effectSciences
Clinical trialSciences
Internal medicineSciences
Randomized controlled trialSciences
Coronavirus disease 2019 (COVID-19)Sciences
PathologySciences
Alternative medicineSciences
Infectious disease (medical specialty)Sciences
DiseaseSciences